chartexchange

Foghorn Stock Sinks as Lilly Scraps Cancer Deal, Forcing 40% Layoffs

Barron's | Oct 1, 2026 3:51 PM EDT

Foghorn Therapeutics and Eli Lilly don’t plan any future collaborations following the dissolution of a cancer-drug partnership.

Read original article